In today’s briefing:
- Chinese Property Weekly – 29 July 2022 – Lucror Analytics
- Chinese Property Weekly – 29 July 2022 – Lucror Analytics
- Cryofocus Medtech (康灃生物科技) Pre-IPO: Unimpressive Fundamentals
- Weekly Wrap – 29 Jul 2022
- Weekly Wrap – 29 Jul 2022
Chinese Property Weekly – 29 July 2022 – Lucror Analytics
The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.
Chinese Property Weekly – 29 July 2022 – Lucror Analytics
The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.
Cryofocus Medtech (康灃生物科技) Pre-IPO: Unimpressive Fundamentals
- Cryofocus Medtech is a China based medical device company with a focus on cryoablation. The company is look to raise $50-100m to list in Hong Kong.
- We take a quick look at Cryofocus’ key products, including AF cryoablation system and bladder cryoablation system.
- We think its products are not impressive. Neither does its investor line-ups and management team impress us much.
Weekly Wrap – 29 Jul 2022
Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.
In this Insight:
- Lifestyle International Holdings
- Vedanta Resources
- Tata Motors Ltd
- China South City
- Seazen (Formerly Future Land)
and more…
Weekly Wrap – 29 Jul 2022
Lucror Analytics Weekly Wraps provide an overview of all Morning Views comments and reports published by our analyst team in the past week, and also showcase a list of the most-read reports.
In this Insight:
- Lifestyle International Holdings
- Vedanta Resources
- Tata Motors Ltd
- China South City
- Seazen (Formerly Future Land)
and more…
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars